Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors

Journal of Liposome Research

Volumn 23, Issue 2, 2013, Pages 94-100

  Hadjidemetriou, Marilena ^a   Pippa, Natassa ^a,b   Pispas, Stergios ^b   Demetzos, Costas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b THEORETICAL AND PHYSICAL CHEMISTRY INSTITUTE   (Greece)

Author keywords

Aggregation kinetics; Colloidal stability; Dimethoxycurcumin; Extended DLVO theory; Fractal dimension

Indexed keywords

CURCUMIN; DIMETHOXYCURCUMIN; LIPOSOME; UNCLASSIFIED DRUG; WATER;

ARTICLE; CHEMICAL REACTION KINETICS; DRUG FORMULATION; DRUG SOLUBILITY; FRACTAL ANALYSIS; HYDRODYNAMICS; KINETICS; LIGHT SCATTERING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

CURCUMIN; FRACTALS; KINETICS; LIPOSOMES; SCATTERING, RADIATION;

EID: 84878436564     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.747534     Document Type: Article

References (44)

1. Al-Jamal WT, Kostarelos K. (2011). Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res 44:1094-104.
2. Baish JW, Jain RK. (2000). Fractals and cancer. Cancer Res 60:3683-8. (Pubitemid 32204551)
3. Basnet P, Hussain H, Tho I, Salko-Basnet N. (2011). Liposomal delivey system enhances anti-inflammatory properties of curcumin. J Pharm Sci 101:598-609.
4. Brú A, Albertos S, Subiza JL, et al. (2003). The universal dynamics of tumor growth. Biophys J 85:2948-61. (Pubitemid 37345785)
5. Delgado AV, Conzález-Caballero F, Hunter RJ, et al. (2007). Measurement and interpretation of electrokinetic phenomena. J Colloid Interface Sci 309:194-224. (Pubitemid 46551101)
6. Derjaguin BV, Landau LD. (1941). Theory of the stability of strongly charged lyophobic sols and of adhesion of strongly charged particles in solution of electrolytes. Acta Physicochim 14:633-62.
7. Duvoix A, Blasius R, Delhalle S, et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181-90. (Pubitemid 40719616)
8. Gardikis K, Hatziantoniou S, Viras K, Demetzos C. (2006). Effect of a bioactive curcumin derivative on DPPC membrane: a DSC and Raman spectroscopy study. Thermochim Acta 447:1-4. (Pubitemid 43994089)
9. González AE, Mart́inez-López F, Moncho-Jordá A, Hildalgo-Alvarez R, (2002). Two-dimensiomal colloidal aggregation: concentration. J Colloid Interface Sci 246:227-34.
10. Gregoriadis G, Wills EJ, Swain CP, Tavill AS. (1974). Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1:1313-16.
11. Gregory J. (2009). Monitoring particle aggregation processes. Adv Colloid Interface Sci 147-8:109-23.
12. Grogan MJ, Rotkina L, Bau HH. (2011). In situ liquid-cell electron microscopy of colloid aggregation and growth dynamics. Phys Rev E 83:061405-5.
13. Heurtault B, Saulnier P, Pech B, et al. (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials 24:4283-300. (Pubitemid 36814076)
14. Huang S, Ernberg I, Kauffman S. (2009). Cancer attractors: a system view of tumors from a gene network dynamics and development perspective. Semin Cell Dev Biol 20:869-76.
15. Hughes GA. (2005). Nanostructure-mediated drug delivery. Nanomedicine 1:22-30. (Pubitemid 43963612)
16. Janecka IP. (2007). Cancer control through principles of systems science, complexity, and chaos theory: a model. Int J Med Sci 4:164-73. (Pubitemid 46879083)
17. Lasic DD. (1993). Liposomes: from physics to applications. Amsterdam: Elsevier.
18. Li L, Braiteh FS, Kurzrock R. (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322-31. (Pubitemid 41282806)
19. Maiti K, Mukherjee K, Gantait A, et al. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155-63. (Pubitemid 46097368)
20. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. (2006). Multiple biological activities of ccurcumin: a short review. Life Sci 78:2081-7.
21. McNally JG, Mazza D. (2010). Fractal geometry in the nucleus. EMBO J 29:1-3.
22. Mishra B, Bhavesh B, Patel B, Tiwari S. (2010). Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedecine 6:9-24.
23. New RRC. (1990). Liposomes: a practical approach. Oxford, UK: IRL Press at Oxford University Press.
24. Newman JD, Cragg MG. (2007). Natural products as sources of new drug over the last 25 years. J Nat Prod 70:461-77.
25. Ohtsu H, Xiao Z, Ishida J, et al. (2002). Antitumor agents. 217: curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 45:5037-42. (Pubitemid 35278699)
26. Okhi S, Ohshima H. (1999). Interaction and aggregation of lipid vesicles (DLVO theory versus modified DLVO theory). Colloids Surf B: Biointerfaces 14:27-45. (Pubitemid 29364273)
27. Pippa N, Demetzos C, Danezis E. (2012a). The formalism of fractal aggregation phenomena of colloidal drug delivery systems. J Liposome Res 22:55-61.
28. Pippa N, Pispas S, Demetzos C. (2012b). The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media. Int J Pharm 430:65-73.
29. Roldán-Vargas S, Barnabas-Rodŕigez R, Mart́in-Molina A, et al. (2008). Growth of lipid vesicle structures: from surface fractals to mass fractals. Phys Rev E 78:1-4.
30. Roldán-Vargas S, Barnabas-Rodrígez R, Quesada-Pérez M, et al. (2009). Surface fractals in liposome aggregation. Am Phys Soc Phys Rev 79:1-14.
31. Sabín J, Prieto G, Ruso JM, et al. (2006). Size and stability of liposomes: a possible role of hydration and osmotic forces. Eur Phys J 20:401-8. (Pubitemid 44386800)
32. 3+: a study of the fractal dimension. Phys Rev E 76:1-7.
33. 2+. Eur Phys J 24:201-10. (Pubitemid 50002814)
34. Sadzuka Y, Nagamine M, Toyooka T, et al. (2012). Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm 432:42-9.
35. Sharma RA, Gescher AJ, Steward WP. (2005). Curcumin: the story so far. Eur J Cancer 41:1955-68. (Pubitemid 41557681)
36. Shimanouchi T, Sasaki M, Hiroiwa A, et al. (2011). Relationship between the mobility of phosphocholine headgroups of liposomes and the hydrophobicity at the membrane interface: a characterization with spectrophotometric measurements. Colloids Surf B: Biointerfaces 88:221-30.
37. Slobodan VJ, Steen S, Charles WB, Michael GS. (1999). H-atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc 121:9677-81.
38. Souza GR, Staquicini FI, Christianson DR, et al. (2010). Combinatorial targeting and nanotechnology applications. Biomed Microdevices 12:597-606.
39. Streba CT, Pirici D, Vere CC, et al. (2011). Fractal analysis differentiation of nuclear and vascular patterns in hepatocel-lular carcinomas and hepatic metastasis. Rom J Morphol Embryol 52:845-54.
40. Tambasco M, Eliasziw M, Magliocco AM. (2010). Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med 8:140.
41. Tamvakopoulos C, Dimas K, Sofianos ZD, et al. (2007). Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin Cancer Res 13:1269-77. (Pubitemid 46424068)
42. Tierney KJ, Block DE, Longo ML, (2005). Elasticity and phase behavior of DPPC membrane modulated by cholesterol, ergosterol and ethanol. Biophys J 89:2481-93. (Pubitemid 41401037)
43. Verwey EJB, Overbeck JThG. (1948). Theory of the stability of lyophobic colloids. Amsterdam: Elsevier.
44. Vogtt K, Joworrek C, Garamus VM, Winter R, (2010). Microdomains in lipid vesicles: structure and distribution assessed by small-angle scattreing. J Phys Chem B 114:5643-8.